OBJECTIVE： To observe therapeutic efficacy of Xinyi biyan pills combined with budilaide in the treatment of allergic rhinitis and its effects on related inflammatory factors.  METHODS： A total od 120 patients with allergic rhinitis were randomly divided into observation group and control group， with 60 cases in each group. Control group was treated with Budesonide nasal spray， spraying once each nostril（64 μg/spray）， 2 times a day. Observation group was additionally treated with Xinyi biyan pills 3 g， 3 times a day. Treatment course lasted for 4 weeks. Clinical efficacies of 2 groups were observed and compared. The changes of total score of clinical symptoms and signs were observed before and after treatment. The contents of IgE and LTE4 were determined， and the occurrence of ADR was recorded. RESULTS： Three patients of observation group and 4 patients of control group fell of the study. Total response rate of observation group was significantly higher than that of control group， with statistical significance （84.21％ vs. 73.21％，P＜0.05）. Before treatment， there was no statistical significance in total score of clinical symptoms and signs， IgE and LTE4 levels between 2 groups （P＞0.05）. After 2 and 4 weeks of treatment， total score of clinical symptoms and signs， IgE and LTE4 levels in 2 groups were significantly lower than before treatment， and the observation group was significantly lower than control group， with statistical significance （P＜0.05）. No obvious ADR was found in 2 groups. CONCLUSIONS： Xinyi biyan pills combined with budesonide show good therapeutic efficacy for allergic rhinitis， improve clinical symptoms and signs significantly and reduce inflammatory factors levels with good safety.